The Effect of Transcranial Direct Stimulation on Cognitive Functions of Healthy Adults
The Effect Of Transcranial Direct Stimulation Applied To The Dorsolateral Prefrontal Cortex And Posterior Parietal Cortex İn Cognitive Function, Mood And Proprioception İn Healthy Adults
Background: Transcranial direct current stimulation(tDCS) has been used to improve cognitive functions in healthy young adults.
Purpose: To investigate the effect of TDCS application on different cortex regions on cognitive function.
Methods: Sixty individuals aged 18-30 were included in the study. The participants were randomly divided into the left dorsolateral prefrontal cortex (Left DLPFC Group)(n=20), the right posterior parietal cortex (Right PPC Group)(n=20), and the sham group (Sham Group)(n=20). tDCS was applied for 20 minutes on weekdays for 2 weeks. The participants were evaluated in terms of cognitive functions with Neuropsychometric Test Battery before and after treatment.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Istanbul, Turquie, 34000
- Damla Ören
-
Istanbul, Turquie, 34000
- Medipol Mega Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- being 18-30 years old
Exclusion Criteria:
- alcohol and substance addiction
- previous mental illness
- having mental and cognitive problems
- a history of head trauma
- having cardiovascular disease.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Diagnostique
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: LEFT DLPFC
The anode electrode of tDCS was applied to the left DLPFC and the cathode electrode was connected to the contralateral shoulder.
|
The intervention protocols were applied using tDCS (Teknofil TESsaNova).
All individuals received 2 mA of anodal tDCS for 2 weeks on weekdays.
All applications were done in the form of 20-minute sessions.
|
|
Comparateur actif: RİGHT PPC
The anode electrode of tDCS was applied to the right PPC and the cathode electrode was connected to the contralateral shoulder.
|
The intervention protocols were applied using tDCS (Teknofil TESsaNova).
All individuals received 2 mA of anodal tDCS for 2 weeks on weekdays.
All applications were done in the form of 20-minute sessions.
|
|
Comparateur factice: Sham
Placebo was applied by placing the electrodes in the right PPC and left DLPFC without applying current.
|
The intervention protocols were applied using tDCS (Teknofil TESsaNova).
All individuals received 2 mA of anodal tDCS for 2 weeks on weekdays.
All applications were done in the form of 20-minute sessions.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Neuropsychiatric Test Battery
Délai: 3 weeks
|
It is a test battery for getting detailed information about general cognitive status.
|
3 weeks
|
|
Beck Depression Scale
Délai: 3 weeks
|
It measures the symptoms seen in depression such as emotional, cognitive and motivational. It includes 21 items determine a behavioral feature related to depression. Items are numbered from 0 to 3. The goal is to objectively break down the degree of symptoms. The total score of all answers is calculated as follows: 0 to 9 points: Minimally depressive symptoms 10 to 16 points: Mild depressive symptoms Between 17 and 29 points: Moderate depressive symptoms Between 30 and 63 points: Severe depressive symptoms |
3 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Lutfu Hanoglu, PhD, Medipol University
- Chercheur principal: Miray BUDAK, PhD, Medipol University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- tDCS on DLPFC and PPC
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .